Trial intelligence / Profile preview

Vitamin E for Treatment of Neonatal Hyperbilirubinemia

IRCT20220806055625N2Phase 3Completed

Sponsor
Kurdistan University of Medical Sciences
Start
Dec 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of vitamin e in neonatal hyperbilirubinemia, sponsored by Kurdistan University of Medical Sciences. Started Dec 2022; status: completed.

02

Drugs

vitamin e
03

Conditions

neonatal hyperbilirubinemia

Beyond the preview

Go deeper on IRCT20220806055625N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220806055625N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call